According to the official, the Centers for Disease Control and Prevention have documented a rise in both infections and hospitalizations attributed to the virus. However, it's worth noting that the overall infection rates are still comparatively low at this point.
Notably, on Thursday, Moderna (MRNA.O) unveiled promising initial findings. These findings indicate that the updated Covid-19 vaccine developed by Moderna remains effective against emerging subvariants such as "Eris" and "Fornax" in the human population.
0 Comments